PRRT2 and prostate carcinoma: Androgen can stimulate the conventional second messenger signal transduction cascades including PKA, protein kinase C (PKC), and mitogen-activated protein kinases (MAPK) in prostate cancer cells [45]–[47] or in skeletal muscle cells through MAPK pathway [48], [49].